Development of Theranostic for Acute Myeloid Leukemia (AML) targeting activated conformation of integrin i (sic)2

Wadhwa, AnjuAnjuWadhwaBobba, KondapaKondapaBobbaMandal, KamalKamalMandalBidkar, AnilAnilBidkarRaveendran, AthiraAthiraRaveendranJohnson, HaleyHaleyJohnsonHuebner, JuwitaJuwitaHuebnerAlvarez, MarinaMarinaAlvarezWilson, DavidDavidWilsonVanBrocklin, HenryHenryVanBrocklinSeo, YounghoYounghoSeoAdams, Jarrett J.Jarrett J.AdamsSidhu, SachdevSachdevSidhuWitta, ArunArunWittaFlavell, RobertRobertFlavell2025-08-282025-08-282024-06-010161-5505http://repository.iitgn.ac.in/handle/IITG2025/19116en-USRadiology, Nuclear Medicine & Medical ImagingDevelopment of Theranostic for Acute Myeloid Leukemia (AML) targeting activated conformation of integrin i (sic)2Conference Paperhttps://v2.sherpa.ac.uk/id/publication/239041535-566701-06-2024WOS:001289165602109